Government Affairs
Refine Search
Biotechnology
Trade body AusBiotech has made preliminary comment regarding the establishment of the Entrepreneurs’ Infrastructure Program (EIP), based on questions posed in the EIP Discussion Paper. 26 June 2014
Pharmaceutical
In order to keep a lid on the escalating cost of drugs, India's drug price regulator has decided to fix a ceiling price on new drugs aimed at treating HIV, cancer, diabetes, cardiovascular diseases, tuberculosis and malaria, reports The Pharma Letter's India correspondent. 16 June 2014
Biotechnology
The annual Australian Biotechnology Industry Position Survey (2014) shows a worrying trend: advanced manufacturing associated with this industry of the future is following traditional manufacturing and there has been a sharp increase in the number of companies heading overseas, the trade group AusBiotech warns. 12 June 2014
Pharmaceutical
The US Senate yesterday confirmed the nomination of Sylvia Mathews Burwell, the current director of the Office of Management and Budget, to serve as the next US Secretary of Health and Human Services, by a vote of 78 to 17. 6 June 2014
article
Here's our take on the week's top stories. 30 May 2014
Pharmaceutical
Bayer HealthCare, one of the business units of German drug major Bayer, is exploring all options for meeting Russia's 2020 regulations for foreign pharma players, country division head Viktor Geisler told BiopharmInsight. 28 May 2014
Generics
The Brazilian Commission for Consumer Protection will soon hold a hearing to discuss the effectiveness of generic drugs, writes Juliane Carvalho writing on Brazil Pharma News (http://www.brazilpharmanews.com). 26 May 2014
Pharmaceutical
Germany’s Merck KGaA has proposed the creation of a global alliance to help the World Health Organization (WHO) achieve its goal of eliminating schistosomiasis worldwide. 20 May 2014
Pharmaceutical
The UK government is moving ahead with plans to amend legislation to attract drug research back to the UK. If the changes go ahead, they will remove risks of patent infringement claims when carrying out clinical and other experimental trials of new drugs, according to Withers & Rogers – one of the UK’s leading firms of patent and trade mark attorneys. 15 May 2014
Pharmaceutical
As the arguments continue over the benefits or otherwise of US pharma giant Pfizer’s £63 billion ($106 billion) proposed takeover offer for Anglo-Swedish drug major AstraZeneca, the latter issued a statement, saying that Pfizer’s latest announcement contains no new proposal nor substantive new information. 13 May 2014
Pharmaceutical
Last week’s meeting of the Greek Pharmaceutical Pricing Committee of the Ministry of Health, which was expected to issue a Corrective Price Bulletin, took the representatives of the pharmaceutical industry by surprise, as once again the Ministry refused to act on the Committee’s recommendation on a correction of all pricing errors, says the Hellenic Association of Pharmaceutical Companies (SfEE). 12 May 2014
Pharmaceutical
The European Federation of Pharmaceutical Industries and Associations (EFPIA) has welcomed the adoption of the second Innovate Medicines Initiative (IMI2) regulation by the European Council. 7 May 2014
Generics
The Australian National Commission of Audit’s complete dismantling and destruction of the Pharmaceutical Benefits Scheme (PBS) via a damaging set of recommendations could have the public erroneously believing that the PBS has failed and must be growing out of control, claims the country’s generics industry. 5 May 2014
Pharmaceutical
The European Federation of Pharmaceutical Industries and Associations (EFPIA) has today announced the launch of its Manifesto for an Integrated Life Sciences Strategy in Europe, aimed at promoting a healthier future for Europe and its citizens. 5 May 2014
Pharmaceutical
Australia’s National Commission of Audit report has recommended sweeping changes to the country’s public services and health care. 1 May 2014
Pharmaceutical
A clarion call has been sounded by Indian government officials, who are unwilling to buckle under pressure from drug multinationals on intellectual property laws. Dismissing US charges over inept intellectual property rights (IPR) in the country, officials have maintained that, if push comes to shove, India would not hesitate to drag the USA to the World Trade Organization’s dispute resolution mechanism, reports The Pharma Letter's India correspondent. 28 April 2014
Pharmaceutical
The Australian Consumer Price Index (CPI) for the March quarter has shown growth in pharmaceutical prices due to the normal mechanics of the Pharmaceutical Benefits Scheme (PBS) safety net. 23 April 2014
Pharmaceutical
Greece's health care system was among the victims of the debt crisis which began four years ago, according to local experts who have recorded its impact on public health and cutbacks in health care provisions, reports China’s state news agency Xinhua. 22 April 2014
Pharmaceutical
The Russian Federal Anti-Monopoly Service is considering tightening the criteria of patentability, in order to reduce the effects of unreasonably granted drug patents in Russia. 14 April 2014
Pharmaceutical
The Ukraine Association of Pharmaceutical Research and Development (APRaD) participated in a meeting with Vice Prime Minister Oleksandr Sych, on Friday, April 4. Yuriy Savko, APRaD executive director, expressed proposals for the development of the pharmaceutical sector on behalf of APRaD member-companies. 14 April 2014
Pharmaceutical
The nomination of Robert F Kennedy Jr — known as RFK Jr — for the role of US Secretary of the Department of Health and Human Services (HHS) President-elect Donald Trump sent shares in vaccine companies sharply downwards. 22 November 2024
article
The UK government has reappointed BioIndustry Association (BIA) chairman Daniel Mahony as its Life Sciences Investment Envoy. 21 November 2024
Pharmaceutical
The Danish government’s newly-unveiled health reform has been praised for tackling chronic disease care and health inequalities while driving health innovation. 18 November 2024
Pharmaceutical
New research published by the European Federation of Pharmaceutical Industries and Associations (EFPIA) provides in-depth analysis of the economic footprint of the pharmaceutical industry in Europe, across member states and compares Europe to other regions of the world. 18 November 2024
Pharmaceutical
Johnson & Johnson has taken legal action to defend a contentious rebate initiative, filing a lawsuit in the US District Court for the District of Columbia. 15 November 2024
Pharmaceutical
The share prices of Pfizer, GSK, Novavax and other vaccine companies were all markedly lower on Friday. This was not due to the publication of disappointing research results in the sphere, or an ominous stance taken by a major regulator on a key filing, but rather a political development that could spell trouble for the vaccines field as a whole. 15 November 2024
Biotechnology
BeiGene has announced plans to rebrand as BeOne Medicines, a move the cancer specialist says reflects its commitment to fighting cancer through collaboration. 15 November 2024
Pharmaceutical
Danish patients are being offered fewer innovative treatments than Norwegians and Swedes, a new estimate from the Danish Medicines Council shows. 11 November 2024
Pharmaceutical
According to the Swedish pharma trade group Lif, it is positive that, in the updated life science strategy, the government expresses an ambition for Sweden to become more attractive for research investments. 11 November 2024
Pharmaceutical
Li Li, Commissioner of China's National Medical Products Administration (NMPA), and Mette Aaboe Hansen, interim director general of Danish Medicines Agency, have signed a letter of intent to promote bilateral cooperation in regulation of drugs and medical devices. 11 November 2024
Pharmaceutical
Following the news that Donald Trump is the winner of the 2024 US Presidential Election, Morningstar Equity analyst Julie Utterback has published a new note about the impact of this on the managed-care industry. 7 November 2024
Pharmaceutical
UK pharma major AstraZeneca, which has invested heavily in China, hosted a sell-side analyst call on Wednesday (November 6) to discuss the recent media reports about ongoing investigations in China. 7 November 2024
Pharmaceutical
Some of the UK’s leading academics and industry professionals have welcomed Chancellor Rachel Reeves’ £520 million ($669 million) pledge to develop the country’s medicine manufacturing capabilities. 6 November 2024
Pharmaceutical
European regulators will decide by December 6 whether Novo Holdings, the controlling shareholder of Danish pharma giant Novo Nordisk, can finalize its $16.5 billion acquisition of contract drug manufacturer Catalent. 5 November 2024
Pharmaceutical
The Danish government is rolling out the red carpet and welcomes several pharmaceutical companies. 4 November 2024
Generics
Medicines for Europe has launched a study of market barriers faced by European generics and biosimilar pharmaceutical companies operating in 11 key third-country markets. 31 October 2024
Pharmaceutical
Following the first Labour budget for 14 years, the Association of the British Pharmaceutical Industry (ABPI) welcomes Chancellor Rachel Reeves’ measures to improve UK life sciences competitiveness. 30 October 2024
Pharmaceutical
HOPO Therapeutics has been awarded a contract valued at up to $226 million from the Biomedical Advanced Research and Development Authority (BARDA). 29 October 2024
Pharmaceutical
The Danish government has presented part of the plan for a future life science strategy, which has been welcomed by the industry. 28 October 2024
Biotechnology
Legend Biotech has removed Genscript Biotech as its majority shareholder, in a move coinciding with rising US concerns over Chinese ties within the biotech sector. 24 October 2024
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Today's issue
Company Spotlight
A US biotech company dedicated to creating oral drugs with an emphasis on indications in virology and immunology.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze